VANCOUVER, British Columbia, February 11, 2026--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:
TD Cowen 46th Annual Health Care Conference, March 4, 2026
KeyBanc Capital Markets Healthcare Forum, March 17, 2026
Bloom Burton & Co. Healthcare Investor Conference, April 21-22, 2026
A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260210650979/en/
Contacts
Inquiries
Media: Tiffany Chiu; [email protected], +1(236)521-6774
Partnering: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005
Investor Relations: Peter Ahn; [email protected], +1(778)729-9116